Sibel Aydin Aksu

An earlier version of this article was presented at 8th Congress on Minimally Invasive Gynaecological Surgery—12–14 February 2026, Istanbul, Türkiye. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The datasets analyzed in this study are not publicly available due to institutional restrictions relating to intellectual property. However, summary data supporting the findings of this study have been included in the article and Supporting Information.

1. Introduction Breast cancer is the most common cancer type in women and the second most common cause of cancer-related death [1]. Early diagnosis and effective treatment markedly improve survival rates. However, it is a heterogeneous disease with different morphologic features, clinical courses, and treatment responses because of tumors’ distinct genomic and immunological diversity. Therefore, personalized management is required.